Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) have been given a consensus rating of "Hold" by the thirteen research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $34.60.
Several analysts have recently issued reports on the stock. Bank of America upped their target price on shares of Oscar Health from $28.00 to $30.00 and gave the company an "underperform" rating in a research report on Thursday, September 17th. Wells Fargo & Company lifted their price target on Oscar Health from $20.00 to $27.00 and gave the stock an "equal weight" rating in a research report on Thursday, August 13th. Stephens reissued an "equal weight" rating and set a $34.00 price objective on shares of Oscar Health in a research note on Thursday, September 17th. Raymond James Financial boosted their price objective on Oscar Health from $34.00 to $42.00 and gave the stock an "outperform" rating in a research note on Friday, September 18th. Finally, Piper Sandler decreased their price objective on Oscar Health from $48.00 to $45.00 and set an "overweight" rating on the stock in a research report on Friday, November 6th.
View Our Latest Stock Report on OSCR
Insider Transactions at Oscar Health
In related news, insider Janet Liang sold 10,360 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $325,822.00. Following the sale, the insider owned 248,697 shares in the company, valued at approximately $7,821,520.65. This represents a 4.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam Mcananey sold 9,092 shares of the stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $285,943.40. Following the sale, the insider owned 209,004 shares in the company, valued at $6,573,175.80. The trade was a 4.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 855,701 shares of company stock worth $26,166,546. 22.64% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of OSCR. Dimensional Fund Advisors LP boosted its holdings in Oscar Health by 22.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company's stock valued at $48,078,000 after acquiring an additional 759,837 shares during the period. Bank of America Corp DE grew its position in Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company's stock valued at $32,808,000 after acquiring an additional 1,922,732 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in Oscar Health by 107.5% in the third quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company's stock worth $79,867,000 after purchasing an additional 1,341,716 shares during the period. Halter Ferguson Financial Inc. increased its stake in Oscar Health by 93.3% in the third quarter. Halter Ferguson Financial Inc. now owns 1,211,825 shares of the company's stock worth $37,373,000 after purchasing an additional 584,818 shares during the period. Finally, Wedge Capital Management L L P NC purchased a new stake in Oscar Health in the second quarter worth $32,855,000. Institutional investors own 75.70% of the company's stock.
Oscar Health Stock Performance
NYSE OSCR opened at $29.96 on Wednesday. The stock has a market capitalization of $9.31 billion, a PE ratio of 12.38, a P/E/G ratio of 0.24 and a beta of 2.56. The business has a 50 day simple moving average of $31.90 and a two-hundred day simple moving average of $24.54. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.16 and a quick ratio of 1.16. Oscar Health has a 1-year low of $10.69 and a 1-year high of $38.50.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.63. Oscar Health had a return on equity of 49.39% and a net margin of 4.90%. The business had revenue of $5.14 billion for the quarter, compared to analysts' expectations of $4.69 billion. During the same period in the prior year, the firm earned ($0.53) EPS. The company's revenue for the quarter was up 72.1% on a year-over-year basis. On average, research analysts predict that Oscar Health will post 2.48 EPS for the current fiscal year.
About Oscar Health
(
Get Free Report)
Oscar Health is a U.S. health insurance company that uses technology and digital tools to connect members with health coverage and care. Founded in 2012, the company initially focused on individual health plans and has expanded its offerings to include coverage for small businesses. Oscar's products include individual and family plans, generally offered through the Affordable Care Act marketplaces, as well as small-group health insurance. Its services include a mobile app and online tools for managing benefits, finding care, and communicating with care teams.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.